204 related articles for article (PubMed ID: 23763570)
1. SIRT1-mediated FoxO1 deacetylation is essential for multidrug resistance-associated protein 2 expression in tamoxifen-resistant breast cancer cells.
Choi HK; Cho KB; Phuong NT; Han CY; Han HK; Hien TT; Choi HS; Kang KW
Mol Pharm; 2013 Jul; 10(7):2517-27. PubMed ID: 23763570
[TBL] [Abstract][Full Text] [Related]
2. Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1.
Oh WK; Cho KB; Hien TT; Kim TH; Kim HS; Dao TT; Han HK; Kwon SM; Ahn SG; Yoon JH; Kim TH; Kim YG; Kang KW
Mol Pharmacol; 2010 Nov; 78(5):855-64. PubMed ID: 20713551
[TBL] [Abstract][Full Text] [Related]
3. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.
Han CY; Cho KB; Choi HS; Han HK; Kang KW
Carcinogenesis; 2008 Sep; 29(9):1837-44. PubMed ID: 18390843
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
Vaziri-Gohar A; Zheng Y; Houston KD
Mol Cancer Res; 2017 Apr; 15(4):489-497. PubMed ID: 28096479
[TBL] [Abstract][Full Text] [Related]
5. Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells.
Choi HK; Yang JW; Roh SH; Han CY; Kang KW
Endocr Relat Cancer; 2007 Jun; 14(2):293-303. PubMed ID: 17639045
[TBL] [Abstract][Full Text] [Related]
6. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
[TBL] [Abstract][Full Text] [Related]
7. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1.
Wang WR; Liu EQ; Zhang JY; Li YX; Yang XF; He YH; Zhang W; Jing T; Lin R
Exp Cell Res; 2015 Oct; 338(1):54-63. PubMed ID: 26226216
[TBL] [Abstract][Full Text] [Related]
8. Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol.
Xia N; Strand S; Schlufter F; Siuda D; Reifenberg G; Kleinert H; Förstermann U; Li H
Nitric Oxide; 2013 Aug; 32():29-35. PubMed ID: 23583951
[TBL] [Abstract][Full Text] [Related]
9. Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver.
Park JM; Kim TH; Bae JS; Kim MY; Kim KS; Ahn YH
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):329-34. PubMed ID: 21078299
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
[TBL] [Abstract][Full Text] [Related]
11. FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.
Singh BK; Sinha RA; Zhou J; Xie SY; You SH; Gauthier K; Yen PM
J Biol Chem; 2013 Oct; 288(42):30365-30372. PubMed ID: 23995837
[TBL] [Abstract][Full Text] [Related]
12. Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
Ryu CS; Kwak HC; Lee JY; Oh SJ; Phuong NT; Kang KW; Kim SK
Biochem Pharmacol; 2013 Jan; 85(2):197-206. PubMed ID: 23123664
[TBL] [Abstract][Full Text] [Related]
13. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
15. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts.
Kim TH; Kim HS; Kang YJ; Yoon S; Lee J; Choi WS; Jung JH; Kim HS
Biochim Biophys Acta; 2015 Feb; 1850(2):401-10. PubMed ID: 25445714
[TBL] [Abstract][Full Text] [Related]
16. Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide.
Sasaki T; Kim HJ; Kobayashi M; Kitamura YI; Yokota-Hashimoto H; Shiuchi T; Minokoshi Y; Kitamura T
Endocrinology; 2010 Jun; 151(6):2556-66. PubMed ID: 20375183
[TBL] [Abstract][Full Text] [Related]
17. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
[TBL] [Abstract][Full Text] [Related]
18. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
Yang Y; Hou H; Haller EM; Nicosia SV; Bai W
EMBO J; 2005 Mar; 24(5):1021-32. PubMed ID: 15692560
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization.
Qiang L; Banks AS; Accili D
J Biol Chem; 2010 Aug; 285(35):27396-27401. PubMed ID: 20519497
[TBL] [Abstract][Full Text] [Related]
20. Gegen Qinlian Decoction Ameliorates Hepatic Insulin Resistance by Silent Information Regulator1 (SIRT1)-Dependent Deacetylation of Forkhead Box O1 (FOXO1).
Sui M; Chen G; Mao X; Wei X; Chen Y; Liu C; Fan Y
Med Sci Monit; 2019 Nov; 25():8544-8553. PubMed ID: 31719515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
